"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
An interview with Brendan O'Brien from Vision Direct, discussing everything from the types of contact lenses available to preventing 'dry eye' and the future potential of smart lenses!
Reducing anemia in developing regions is a key strategic health goal with a prevalence of more than 60% in some developing countries.
Sqn Ldr Robert M. Gifford from the University of Edinburgh discusses the latest endocrinological research from the front line, and what his talk will cover at Medical Innovation 2018.
There are many definitions of hard-to-heal. More conventionally, it's based on underlying etiology of the wound, but in practice it's any wound that has not healed within a timely fashion. This is often due to a lack of coordinated care.
Currently, stress echocardiograms used to diagnose heart disease are only 80% accurate, meaning many patients are misdiagnosed or sent home. Ultromics have developed a tool that uses machine learning to gather data and improve the accuracy of heart disease diagnoses to over 90%.
Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.
The way that sick children are taught about their condition is outdated and often doesn't cater to their needs. Dom Raban from Corporation Pop is hoping to change that, through the development of an app that uses artificial intelligence to answer any questions children may have about their care in real-time.
Analytica is a very important show for us and our German team. We have a lot of local customers from Germany, so it is really good event for us to be able to provide face to face interaction with our customers and show them our full range of products all at once.
Cord blood has been studied extensively for the treatment of hematological diseases such as cancer and sickle cell anemia, but is now in phase II trials for the alleviation of autism. Dr. Ann Smith, director of Smart Cells who provided the cord blood for the trial, discusses the research and it's potential.
Hand hygiene is critical to preventing the spread of infection in hospitals. Current methods are outdated, and new technologies are expensive. Zoono's products offer an alternative to alcohol-based hand sanitizers that protect the skin's surface for longer.
Liva Healthcare is an innovative digital health coaching platform for scalable lifestyle and disease management. In the Liva digital healthcare app, a patient is given a healthcare professional coach to help them change their lifestyle or live with their disease.
It is important to select the proper camera for fluorescence microscopy which has high sensitivity and low noise, to avoid photo bleaching your sample. A monochrome camera is also preferred for fluorescence imaging because it does not have a color filter pattern superimposed over the image sensor. Since the microscope’s filter wheel selects which wavelength makes its way to the sensor, a monochrome camera allows equal signal detection on all pixels and increases the overall sensitivity of the camera.
We know that exercise is beneficial in helping someone to maintain their lung function, stay strong and active and maintain a good quality of life. We also know that exercise can complement ‘airway clearance techniques’ – breathing exercises prescribed by physiotherapists to help clear the lungs of mucus.
Samuel Lesko has more than 20 years experiences in running AFM over variety of applications.
After obtaining a PhD at Burgundy university on colloidal force measurement in cement, he started his career at Veeco Instruments as French Applications Scientists before to continue on supporting Bio Applications AFM European wide. He is since 2007 Applications manager for Europe, Middle East and Africa. Recently, his position expanded to Latin America.
Paul Morris is the Director of Professional Advancement for Specsavers Opticians in the UK and Ireland. The role involves furthering clinical scope, professional services, standards, training and forming future strategy for the group. He previously held the role of Director of Optometry Advancement.
The World Health Organisation marked World Pneumonia Day on November 12th to promote interventions to protect against, prevent and treat pneumonia. The condition is a worldwide killer affecting people of all ages, however the ‘aging population’ is at an increased risk.
There are about 77,000 people known to have cystic fibrosis. That's from the various cystic fibrosis registries available globally. The World Health Organization suggests that this number may be low, because there's no reporting on cystic fibrosis from the developing world. The accepted number, at the moment, is about 80,000. That's the one that is used for most of the work that's being done on cystic fibrosis.
Autism is a clinical diagnosis. There is no one test to diagnose autism. Depending on the type of medical professional diagnosing, typically the DSM-V (standard classification of mental disorders used by mental health professionals in the U.S.) is used to diagnose by primary care physicians, neurologists, and psychiatrists.
There are two problems that pathologists face today. The first is, that a pathologist’s diagnosis using tissue sections is becoming more complex. There are many more biomarkers, and clinicians now ask for a more precise diagnosis. Secondly, the number of pathologists worldwide is declining every day, as the profession is often overlooked in favor of other specializations.
Leveraging the mass production benefit that MultiBrain® technology brings to neurohistology, NSA can accelerate the R&D preclinical and safety assessment processes many fold and perform them less expensively. This results in faster times for a potential drug to move from R&D to clinical trials and sooner for use in people.